Is Staphylococcus epidermidis isolated from a urine specimen a contaminant or indicative of a true urinary tract infection?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 18, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Staphylococcus epidermidis in Urine: Contaminant vs. Pathogen

Staphylococcus epidermidis isolated from urine is almost always a contaminant, particularly when present at low colony counts (<1,000 CFU/mL) or as part of mixed flora, and should not be treated in the vast majority of cases. 1

When S. epidermidis is Contamination

Coagulase-negative staphylococci (including S. epidermidis) at low colony counts (<1,000 CFU/mL) are not clinically relevant urine isolates and represent skin flora contamination. 1 The following features strongly indicate contamination:

  • Mixed growth with ≥2 organisms at any concentration suggests specimen contamination from periurethral, vaginal, or perineal skin flora rather than true infection 1, 2
  • High epithelial cell counts on urinalysis indicate skin cells were shed during collection, rendering the culture unreliable 3
  • Collection method matters critically: clean-catch specimens have 14-32% contamination rates, while bag-collected specimens have 44-68% contamination rates 1, 2

Rare Exceptions: When S. epidermidis May Be Pathogenic

S. epidermidis can occasionally cause true UTI in highly specific clinical contexts, though this remains uncommon:

High-Risk Populations

  • Children with anatomic urinary tract abnormalities (e.g., severe vesicoureteral reflux grade III-V) may develop S. epidermidis UTI 4, 5
  • Patients with indwelling urinary catheters or recent instrumentation are at risk for coagulase-negative staphylococcal UTI 4, 5
  • Patients on continuous antibiotic prophylaxis may develop breakthrough S. epidermidis infections due to selective pressure 5

Supporting Evidence for True Infection

When S. epidermidis is a true pathogen (rare), you will see:

  • Pure growth of S. epidermidis as a single organism (not mixed flora) at ≥50,000 CFU/mL 1, 3
  • Pyuria (≥10 WBCs/mm³) with bacteriuria increases likelihood of true infection 1
  • Positive leukocyte esterase or nitrites suggest infection despite the unusual organism 1
  • Gram stain of properly collected urine showing gram-positive cocci in a symptomatic patient 5
  • Symptoms of pyelonephritis (fever, flank pain) with no other pathogen identified 5, 6

Clinical Decision Algorithm

Step 1: Assess Collection Method and Specimen Quality

  • If mixed flora or epithelial cells present: Contamination—do not treat 1, 2, 3
  • If bag-collected specimen in children: 85% false positive rate—never use to confirm UTI 2

Step 2: Evaluate Colony Count and Organism Purity

  • <1,000 CFU/mL: Contamination—do not treat 1, 3
  • ≥50,000 CFU/mL of S. epidermidis as single organism: Proceed to Step 3 3

Step 3: Assess Clinical Context

  • No urinary symptoms + no risk factors: Contamination—do not treat 2
  • Symptomatic + anatomic abnormality or catheter/instrumentation: Consider true pathogen—obtain repeat specimen by catheterization or suprapubic aspiration 1, 2, 4
  • Symptomatic + no risk factors + no pyuria: Contamination—recollect specimen 1

Step 4: Confirm Before Treating

Never treat based on a single contaminated culture. 2 If clinical suspicion remains high:

  • Obtain catheterized specimen (≥50,000 CFU/mL threshold) or suprapubic aspiration (any growth significant) 2, 3
  • Verify pyuria is present (absence suggests contamination or asymptomatic bacteriuria) 1

Critical Pitfalls to Avoid

  • Do not automatically treat S. epidermidis in urine—it is contamination in >95% of cases 1, 4
  • Do not treat asymptomatic patients based on S. epidermidis growth, as this leads to inappropriate antibiotic use 2
  • Do not accept bag-collected specimens as diagnostic in children—contamination rate is 60-68% 2
  • Do not ignore specimen processing delays—urine held at room temperature >1 hour yields falsely elevated counts 2, 3
  • In children with gram-positive cocci on urine Gram stain, consider enterococci first, then S. saprophyticus (a true uropathogen), before attributing infection to S. epidermidis 5, 7, 8

References

Guideline

Urine Contamination and Clinical Decision-Making

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Management of Urine Culture with Mixed Flora

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Urinary Tract Infection Diagnosis Based on Colony Counts

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Related Questions

What is the treatment for a urinary tract infection caused by Staphylococcus epidermidis in urine?
What does Staphylococcus saprophyticus (S. saprophyticus) in a urine test indicate?
In an asymptomatic patient without urinary catheter or other risk factors, is methicillin‑resistant Staphylococcus epidermidis isolated from a urine culture considered a contaminant?
Is Staphylococcus (S.) epidermidis a potential urinary tract infection (UTI) pathogen and what antibiotics can be used to treat it?
Can cefalexin (cephalexin) be used to treat Staphylococcus saprophyticus pyelonephritis urinary tract infection (UTI)?
In an elderly woman with Alzheimer disease who is exhibiting aggressive behavior, what medication should be started?
What is the appropriate initial management for a 32‑year‑old severely obese patient with left knee pain, a giving‑out sensation, laxity with hyperextension, and mild osteoarthritis on X‑ray?
When is lurasidone (Latuda) indicated for use in clinical practice?
Can you interpret the X‑ray of an elderly patient showing generalized reduced bone mineral density, mild levoscoliosis of the lower thoracic spine with a Cobb angle of 24.5°, mild‑to‑moderate disc‑space narrowing at multiple levels, no compression fractures, normal overall alignment, and no focal lytic or blastic lesions?
Why is metamizol (dipyrone) not marketed or approved in the United States and other countries, and what solid evidence supports this restriction?
What is the appropriate treatment for trigger finger in an adult?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.